#USA #New York #Class-action Lawsuit #Regencell Bioscience #RGC

Regencell Bioscience Shareholder Alert

Investors in Regencell Bioscience Holdings Limited (NASDAQ: RGC) who have experienced losses can pursue justice through a class-action lawsuit led by The Gross Law Firm. This legal notice aims to inform shareholders who purchased shares during the specified class period from October 28, 2024, to October 31, 2025.

Allegations Against Regencell

During this prescribed period, the allegations state that Regencell's management issued materially false and misleading statements. Furthermore, the company is claimed to be vulnerable to market manipulation. Consequently, this situation led to significant financial risks for investors, as the volatility in the market for Regencell's shares created a precarious environment.

The lawsuit underscores that Regencell was exposed to regulatory scrutiny, both governmental and media. This potential oversight could result in severe legal and reputational damage to the company, and ultimately burden shareholders with financial loss.

How to Participate

Shareholders of RGC are encouraged to register their details on the Gross Law Firm's website. Even if one doesn’t desire the lead plaintiff role, participation still allows shareholders to seek financial recovery from the losses incurred during the class period. The contact information for the law firm indicates urgency, underscoring that the deadline to seek lead plaintiff status is June 23, 2026.

On enrolling with the firm, shareholders will receive ongoing updates through a monitoring software that keeps them informed on the case’s status. This feature provides essential insights and guidance through the legal process.

Why Choose The Gross Law Firm?

Recognized nationally for its work in class-action lawsuits, The Gross Law Firm prides itself on protecting the rights of investors affected by corporate misconduct. Their goal is to recover losses for investors who have been harmed by deceitful actions, ensuring that corporations remain accountable. With a dedication to furthering responsible business conduct, The Gross Law Firm stands as a beacon of hope for those seeking restitution.

For shareholders looking to get involved, more information can be found at their official website.

In conclusion, if you are a shareholder who has faced financial loss in Regencell Bioscience Holdings Limited, now is the time to act. Register your details before the looming deadline to ensure your rights as an investor are honored and to make a potential recovery from any financial loss.

For further assistance or details, reach out to the Gross Law Firm directly at their New York City office or contact them via email or phone as provided in the notice. Act now and secure your position in the class action!